Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TLK199 in Myelodysplastic Syndrome
NCT00035867Phase 2Completed
- Sponsor
- Telik, Inc.
- Start
- Apr 2002
- Modality
- Peptides, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ezatiostat in myelodysplastic syndrome (MDS), sponsored by Telik, Inc.. Started Apr 2002; status: completed.
02
Drugs
ezatiostat
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00035867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035867.